Skip to main content
Caplight Logo









InHandPlus

InHandPlus

Private
SeoulHealthcare & Life Scienceshttps://inhandplus.com/

Last Round

Series A

Jul 7, 2023

Total Funding Raised

$3.68M

Company Overview

InHandPlus is a healthcare technology company that provides an AI-based smartwatch and application for medication management.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Devices, Patient Engagement, Medical AI, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

medication adherenceremote patient monitoringRPMdecentralized clinical trialsDCTreal-world evidenceRWEwearable health techdigital healthmedication managementclinical research organizationCROsmart pill bottlebehavior recognitionhealth IoTmedication tracker

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InHandPlus Comparables

Compare InHandPlus with similar companies based on industry and business-model similarity.

InHandPlus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RxCap
79%
Vivalink
75%
etectRx
72%

InHandPlus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 7, 2023
Pre SeedNov 25, 2020
GrantJul 1, 2019
SeedJun 27, 2019

Key People

Founding team and executive leadership

Hwiwon Lee

Founder CEO

Founding Team

InHandPlus Investors

Notable investors and investment history

InHandPlus investors
InvestorRounds
GenaxisSeries A
Strong VenturesPre Seed, Series A
IPS VenturesPre Seed, Series A
Maple Investment PartnersSeries A
POSTECH HoldingsPre Seed, Seed, Grant
Muirwoods VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2026

    Added Biozka, a startup in the pharmaceutical industry, as a customer.

  • Nov 25, 2020

    Raised $1.35M from POSTECH Holdings and Strong Ventures.

InHandPlus Filings

Explore SEC and related filing metadata, where available.

InHandPlus filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InHandPlus's valuation, stock price, and market status.

Is InHandPlus a public or private company?

InHandPlus is a private company.

What is the current stock price of InHandPlus?

InHandPlus is a private company, so its shares have no public market price. Caplight tracks InHandPlus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is InHandPlus worth (valuation)?

Valuation information for InHandPlus is not publicly available.

Can I buy InHandPlus stock?

InHandPlus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was InHandPlus's last funding round?

InHandPlus's most recent funding round was Series A on July 7, 2023.

Who are the main investors in InHandPlus?

Key investors in InHandPlus include Genaxis, Strong Ventures, IPS Ventures, Maple Investment Partners, POSTECH Holdings.

Will InHandPlus IPO soon?

No public IPO plans have been announced for InHandPlus.

How can I track InHandPlus secondary market activity?

Caplight tracks bids, offers, and trades in InHandPlus's shares on secondary markets.

Firmographic Details

HeadquartersSeoul
Employee Range7
Year Founded2019
Last FundingJul 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?